Polymorphisms in NF-κB inhibitors and risk of epithelial ovarian cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  White, Kristin L ^a   Vierkant, Robert A ^a   Phelan, Catherine M ^b   Fridley, Brooke L ^a   Anderson, Stephanie ^a   Knutson, Keith L ^a   Schildkraut, Joellen M ^c   Cunningham, Julie M ^a   Kelemen, Linda E ^d   Shane, V Shane ^a   Rider, David N ^a   Liebow, Mark ^a   Hartmann, Lynn C ^a   Sellers, Thomas A ^b   Goode, Ellen L ^a  

^a Mayo Clinic College of Medicine   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY   (United States)

^d Alberta Cancer Board ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NFKBIA PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MIDDLE AGED; OVARY TUMOR;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; I-KAPPA B PROTEINS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 67651009568     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-170     Document Type: Article

References (32)

1. Jemal A Siegel R Ward E Hao Y Xu J Murray T Thun MJ Cancer statistics, 2008 CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010 18287387
2. Whittemore AS Harris R Itnyre J Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group Am J Epidemiol 1992, 136(10):1184-1203. 1476141
3. Antoniou AC Easton DF Risk prediction models for familial breast cancer Future oncology (London, England) 2006, 2(2):257-274. 10.2217/ 14796694.2.2.257 16563094
4. Risch HA McLaughlin JR Cole DE Rosen B Bradley L Kwan E Jack E Vesprini DJ Kuperstein G Abrahamson JL et al Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 2001, 68(3):700-710. 1274482 11179017 10.1086/318787
5. Dong LM Potter JD White E Ulrich CM Cardon LR Peters U Genetic susceptibility to cancer: The role of polymorphisms in candidate genes Jama 2008, 299(20):2423-2436. 10.1001/jama.299.20.2423 18505952
6. Fathalla MF Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971, 2(7716):163. 10.1016/S0140-6736(71)92335-X 4104488
7. Bonello N McKie K Jasper M Andrew L Ross N Braybon E Brannstrom M Norman RJ Inhibition of nitric oxide: Effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat Biology of reproduction 1996, 54(2):436-445. 10.1095/biolreprod54.2.436 8788197
8. Zackrisson U Mikuni M Wallin A Delbro D Hedin L Brannstrom M Cell-specific localization of nitric oxide synthases (NOS) in the rat ovary during follicular development, ovulation and luteal formation Human reproduction (Oxford, England) 1996, 11(12):2667-2673. 9021370
9. Schildkraut JM Bastos E Berchuck A Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer J Natl Cancer Inst 1997, 89(13):932-938. 10.1093/jnci/89.13.932 9214672
10. Ahn KS Sethi G Aggarwal BB Nuclear factor-kappa B: From clone to clinic Current molecular medicine 2007, 7(7):619-637. 10.2174/ 156652407782564363 18045141
11. Sethi G Sung B Aggarwal BB Nuclear factor-kappaB activation: From bench to bedside Experimental biology and medicine (Maywood, NJ) 2008, 233(1):21-31. 10.3181/0707-MR-196
12. Inoue J Gohda J Akiyama T Semba K NF-kappaB activation in development and progression of cancer Cancer Sci 2007, 98(3):268-274. 10.1111/ j.1349-7006.2007.00389.x 17270016
13. Li H Lin X Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation Cytokine 2008, 41(1):1-8. 10.1016/ j.cyto.2007.09.016 18068998
14. Naugler WE Karin M NF-kappaB and cancer-identifying targets and mechanisms Curr Opin Genet Dev 2008, 18(1):19-26. 2587362 18440219 10.1016/j.gde.2008.01.020
15. Curiel TJ Coukos G Zou L Alvarez X Cheng P Mottram P Evdemon-Hogan M Conejo-Garcia JR Zhang L Burow M et al Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 2004, 10(9):942-949. 10.1038/nm1093 15322536
16. Xiao CW Yan X Li Y Reddy SA Tsang BK Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein Endocrinology 2003, 144(2):623-630. 10.1210/en.2001-211024 12538625
17. Takeyama H Wakamiya N O'Hara C Arthur K Niloff J Kufe D Sakarai K Spriggs D Tumor necrosis factor expression by human ovarian carcinoma in vivo Cancer Res 1991, 51(16):4476-4480. 1868469
18. Hassan MI Kassim SK Saeda L Laban M Khalifa A Ovarian cancer-induced immunosuppression: Relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue Anticancer Res 1999, 19(6C):5657-5662. 10697636
19. Spriggs DR Imamura K Rodriguez C Sariban E Kufe DW Tumor necrosis factor expression in human epithelial tumor cell lines J Clin Invest 1988, 81(2):455-460. 329591 2828427 10.1172/JCI113341
20. Tergaonkar V Correa RG Ikawa M Verma IM Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity Nat Cell Biol 2005, 7(9):921-923. 10.1038/ncb1296 16136188
21. Weil R Israel A Deciphering the pathway from the TCR to NF-kappaB Cell Death Differ 2006, 13(5):826-833. 10.1038/sj.cdd.4401856 16439988
22. Braun T Carvalho G Fabre C Grosjean J Fenaux P Kroemer G Targeting NF-kappaB in hematologic malignancies Cell Death Differ 2006, 13(5):748-758. 10.1038/sj.cdd.4401874 16498458
23. Osborne J Lake A Alexander FE Taylor GM Jarrett RF Germline mutations and polymorphisms in the NFKBIA gene in Hodgkin lymphoma Int J Cancer 2005, 116(4):646-651. 10.1002/ijc.21036 15858823
24. Spink CF Gray LC Davies FE Morgan GJ Bidwell JL Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma Cancer Lett 2007, 246(1-2):92-99. 10.1016/j.canlet.2006.02.001 16540234
25. Gao J Pfeifer D He LJ Qiao F Zhang Z Arbman G Wang ZL Jia CR Carstensen J Sun XF Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations Scandinavian journal of gastroenterology 2007, 42(3):345-350. 10.1080/00365520600880856 17354114
26. Bu H Rosdahl I Sun XF Zhang H Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients J Cancer Res Clin Oncol 2007, 133(11):859-866. 10.1007/s00432-007-0228-7 17492467
27. Sellers TA Schildkraut JM Pankratz VS Vierkant RA Fredericksen ZS Olson JE Cunningham JM Taylor W Liebow M McPherson CP et al Estrogen bioactivation, genetic polymorphisms, and ovarian cancer Cancer Epidemiol Biomarkers Prev 2005, 14(11 Pt 1):2536-2543. 10.1158/ 1055-9965.EPI-05-0142 16284375
28. Cunningham JM Sellers TA Schildkraut JM Fredericksen ZS Vierkant RA Kelemen LE Gadre M Phelan CM Huang Y Meyer JG et al Performance of amplified DNA in an Illumina GoldenGate BeadArray assay Cancer Epidemiol Biomarkers Prev 2008, 17(7):1781-1789. 10.1158/1055-9965.EPI-07-2849 18628432
29. Carlson CS Eberle MA Rieder MJ Yi Q Kruglyak L Nickerson DA Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium Am J Hum Genet 2004, 74(1):106-120. 1181897 14681826 10.1086/381000
30. Seattle SNPs: Variation Discovery Resource http://pga.mbt.washington.edu
31. Oliphant A Barker DL Stuelpnagel JR Chee MS BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping Biotechniques 2002(Suppl):56-58. 12083399
32. Schaid DJ Rowland CM Tines DE Jacobson RM Poland GA Score tests for association between traits and haplotypes when linkage phase is ambiguous Am J Hum Genet 2002, 70(2):425-434. 384917 11791212 10.1086/ 338688